Friday, 16 October 2026European Markets

2020 BULKERS, HYDRATEC, Another 3 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - 2020 bulkers (2020.ol), hydratec (hydra.as), eurasia fonc inv (efi.pa) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
2020 bulkers (2020.ol) 7.15% 2023-12-06 08:24:01
hydratec (hydra.as) 6.38% 2023-12-06 08:02:33
eurasia fonc inv (efi.pa) 5.78% 2023-12-03 07:46:04
chausseria (chsr.pa) 3.13% 2023-12-06 09:01:11
legrand (lr.pa) 2.34% 2023-12-06 09:05:46

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. 2020 bulkers (2020.ol)

7.15% foward dividend yield

2020 bulkers's last close was kr119.40, 3.29% higher than its 52-week high of kr115.60. intraday change was -1.59%.

2020 bulkers ltd. owns and operates large dry bulk vessels worldwide. it operates eight scrubber fitted 208,000 deadweight tonnage newcastlemax dry bulk vessels. the company was incorporated in 2017 and is based in hamilton, bermuda.

earnings per share

as for profitability, 2020 bulkers has a trailing twelve months eps of kr7.99.

pe ratio

2020 bulkers has a trailing twelve months price to earnings ratio of 14.71. meaning, the purchaser of the share is investing kr14.71 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.64%.

more news about 2020 bulkers.

2. hydratec (hydra.as)

6.38% foward dividend yield

hydratec's last close was €89.50, 4.79% under its 52-week high of €94.00. intraday change was -1.12%.

hydratec industries nv, through its subsidiaries, engages in the manufacture and sale of industrial systems and plastic components for food, health, and mobility markets in the netherlands, rest of europe, asia, north america, south america, africa, and oceania. it develops and produces sterilized product handling systems; and automated packaging solutions, including packaging for sterilized food in pouches, tins, and jars, as well as meal salads and agrifood in bags, nets, boxes, and crates. the company also supplies industrial incubators to produce day-old chicks; hatchery automation systems for processing of hatchery eggs and day-old chicks; climate control equipment for air and water treatment; hatchery management software for monitoring, analyzing, and optimizing of the incubation process; and service and support for hatchery systems operation. in addition, it manufactures extrusion equipment for pvc, pvc-o, and po pipes; plastic injection molding products for use in climate control systems, lorries, bicycle parts, and coffee machines; rubber, metal, and plastic precision components, that includes dosing systems, functional and safety parts for braking systems, and cartridges for diagnostics and other medical applications. hydratec industries nv is headquartered in amersfoort, the netherlands.

earnings per share

as for profitability, hydratec has a trailing twelve months eps of €11.85.

pe ratio

hydratec has a trailing twelve months price to earnings ratio of 7.47. meaning, the purchaser of the share is investing €7.47 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.33%.

volatility

hydratec's last week, last month's, and last quarter's current intraday variation average was a negative 0.18%, a positive 0.26%, and a positive 1.56%.

hydratec's highest amplitude of average volatility was 3.14% (last week), 1.79% (last month), and 1.56% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, hydratec's stock is considered to be overbought (>=80).

volume

today's last reported volume for hydratec is 388 which is 580.7% above its average volume of 57.

revenue growth

year-on-year quarterly revenue growth grew by 7.9%, now sitting on 293m for the twelve trailing months.

more news about hydratec.

3. eurasia fonc inv (efi.pa)

5.78% foward dividend yield

eurasia fonc inv's last close was €0.28, 36.77% below its 52-week high of €0.45. intraday change was 0%.

eurasia fonciere investissements société anonyme, through its subsidiaries, engages in holding and acquiring real estate assets in france and internationally. it is involved in the development and rental of residential and commercial properties. the company was formerly known as mb retail europe and changed its name to eurasia fonciere investissements société anonyme in january 2012. the company was founded in 1984 and is headquartered in paris, france. eurasia fonciere investissements société anonyme operates as a subsidiary of eurasia groupe sa.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.35%.

moving average

eurasia fonc inv's worth is way under its 50-day moving average of €0.37 and way below its 200-day moving average of €0.33.

more news about eurasia fonc inv.

4. chausseria (chsr.pa)

3.13% foward dividend yield

chausseria's last close was €9.00, 18.18% below its 52-week high of €11.00. intraday change was 0%.

chausseria designs, manufactures, and markets women's shoes. the company markets its products under the chausseria and janie philip brands. chausseria is headquartered in paris, france.

earnings per share

as for profitability, chausseria has a trailing twelve months eps of €1.06.

pe ratio

chausseria has a trailing twelve months price to earnings ratio of 8.49. meaning, the purchaser of the share is investing €8.49 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.34%.

volume

today's last reported volume for chausseria is 23 which is 43.75% above its average volume of 16.

moving average

chausseria's value is way above its 50-day moving average of €7.56 and way above its 200-day moving average of €6.07.

revenue growth

year-on-year quarterly revenue growth grew by 30.7%, now sitting on 2.87m for the twelve trailing months.

more news about chausseria.

5. legrand (lr.pa)

2.34% foward dividend yield

legrand's last close was €89.78, 3.69% below its 52-week high of €93.22. intraday change was 1.96%.

legrand sa, together with its subsidiaries, provides electrical and digital building infrastructures worldwide. the company offers mcbs, rcds, and din rail equipment, including residual current circuit breakers, rcbos, add-on modules and accessories, surge protective devices, other control and signaling devices, and time and light-sensitive switches, as well as dimmers, relays, transformers, power supplies, and accessories; acbs, mccbs, head equipment, and busbar systems; enclosures and accessories; equipment and accessories; home network, home automation, and hotel equipment; wiring accessories; weatherproof wiring accessories and other installation equipment; lighting management, emergency lighting, access control, and safety equipment; ups and lcs products, cable management systems, equipment, and accessories; and mosaic wiring accessories. its products are used in hotels, offices, data centers, shopping centers, health care, industries, residential buildings. the company was founded in 1865 and is headquartered in limoges, france.

earnings per share

as for profitability, legrand has a trailing twelve months eps of €4.2.

pe ratio

legrand has a trailing twelve months price to earnings ratio of 21.8. meaning, the purchaser of the share is investing €21.8 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.21%.

more news about legrand.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com